Global In-Silico Drug Discovery Industry Forecasts to 2029 - Integration of Blockchain Technology in Interoperability Presents Massive Opportunities

DUBLIN, Feb. 14, 2020 /PRNewswire/ -- The "Global In-Silico Drug Discovery Market: Focus on Products, Technologies, Workflow, End Users, Country Data (17 Countries), and Competitive Landscape - Analysis and Forecast, 2018-2029" report has been added to ResearchAndMarkets.com's offering.

The in-silico drug discovery industry analysis projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029. The in-silico drug discovery market generated $2,094.5 million in revenue in 2018, in terms of value.

The global in-silico drug discovery market growth has been primarily attributed to the major drivers in this market such as an emphasis on the reduction in medical errors and readmission rates, growth in the biomarker identification market and advancements in In-silico drug discovery techniques, and computational technological advancements in the field of computational biology.

However, there are significant challenges that are restraining the market growth. These challenges include the high cost of methods and expensive procedures and their applications in medical treatments.

Expert Quote

North America is the leading contributor to the in-silico drug discovery market and contributed approximately 41.65% to the global market value in 2018. This region is anticipated to grow at a significant CAGR during the forecast period 2019-2029 and continue dominating the global market in 2029. However, the Asia-Pacific region is expected to grow at the highest CAGR of 13.29% during the forecast period. In addition, the region of Europe also contributed a significant share of 28.40% to the global market in 2018.

Scope of the Market Intelligence

The in-silico drug discovery research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the service market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global in-silico drug discovery market.

Key Companies in the Market

The key manufacturers who have been contributing significantly to the global in-silico drug discovery market include Albany Molecular Research Inc., Certara USA, Inc., Charles River, Chemical Computing Group ULC, Collaborative Drug Discovery Inc., Dassault System (Biovia), Evotec A.G., GVK Biosciences Private Limited, ICAGEN, INC., Novo Informatics Pvt. Ltd., Numerate Inc., PerkinElmer Inc, Schrdinger, LLC, Selvita, Simulation Plus, and WuXi AppTec, among others.

Key Questions Answered in the Report

• What are the major market drivers, challenges, and opportunities in the global in-silico drug discovery market?
• What are the underlying structures resulting in the emerging trends within the global in-silico drug discovery market?
• How is each segment of the global in-silico drug discovery market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
• What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
• What are the key applications in the global in-silico drug discovery market? What are the major segments of these applications?
• Who are the key manufacturers of the global in-silico drug discovery market, and what are their contributions?

Key Topics Covered

1 Product Definition
1.1 Inclusion and Exclusion

2 Research Scope
2.1 Scope of the Study
2.2 Key Questions Answered in the Report

3 Research Methodology
3.1 Global In-Silico Drug Discovery Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model

4 Industry Analysis
4.1 Regulatory Framework
4.1.1 Regulatory Framework in North America
4.1.2 Regulatory Framework in Europe
4.1.3 Regulatory Framework in Asia-Pacific

5 Competitive Landscape
5.1 Mergers and Acquisitions
5.2 Product Launches and Product Updates
5.3 Synergistic Activities
5.4 Business Expansion Activities and Others
5.5 Market Share Analysis

6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 Emphasis on Reduction in Medical Errors and Readmission Rates
6.3.2 Growth in the Biomarker Identification Market and Advancements in In-Silico Drug Discovery Techniques
6.3.3 Technological Advancements in the Field of Computational Biology
6.4 Market Restraints
6.4.1 Lack of High Complexity Testing Centers
6.4.2 Expensive Procedures and Their Applications in Medical Treatments
6.4.3 High Capital Requirement Hampering the Expansion of Global Reach
6.5 Market Opportunities
6.5.1 Massive Scope for Adoption of In-Silico Drug Discovery in Developing Nations
6.5.2 Integration of Blockchain Technology in Interoperability
6.5.3 Collaborations With Precision Medicine Providers

7 In-Silico Drug Discovery: Overview
7.1 Introduction
7.2 Market Availability for In-Silico Drug Discovery
7.3 In-Silico Drug Discovery Market Technology Trends

8 Global In-Silico Drug Discovery Market (by Workflow)
8.1 Overview
8.2 Discovery
8.2.1 Target Identification
8.2.1.1 Bioinformatics
8.2.1.2 Reverse Docking
8.2.1.3 Protein Structure Prediction
8.2.2 Target Validation
8.2.3 Lead Discovery
8.2.3.1 Library Design
8.2.3.2 Pharmacophore
8.3 Pre-Clinical Tests
8.4 Clinical Trials

9 Global In-Silico Drug Discovery Market (by Product)
9.1 Software
9.2 Software as-a-Service (Cloud)
9.3 Consultancy as-a-Service

10 Global In-Silico Drug Discovery Market (by Software Type)
10.1 Molecular Modeling and de Novo Drug Design Software
10.2 Pharmacophore Modeling Software

11 Global In-Silico Drug Discovery Market (by End-user)
11.1 Contract Research Organizations
11.2 Pharmaceutical Industry
11.3 Academic and Research Institutes
11.4 Other End-users (Hospitals and Other Care Facilities)

12 Global In-Silico Drug Discovery Market, by Region
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 U.K.
12.3.4 Italy
12.3.5 Spain
12.3.6 Russia
12.3.7 Rest-of-Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 Australia
12.4.4 India
12.4.5 South Korea
12.4.6 Rest-of-APAC
12.5 Latin America
12.5.1 Brazil
12.5.2 Mexico
12.6 Rest-of-the-World

13 Company Profiles
13.1 Overview
13.2 Albany Molecular Research Inc.
13.2.1 Company Overview
13.2.2 Role of Albany Molecular Research in the Global In-Silico Drug Discovery Market
13.2.3 SWOT Analysis
13.3 Certara USA Inc.
13.4 Charles River
13.5 Chemical Computing Group ULC
13.6 Collaborative Drug Discovery Inc.
13.7 Dassault System (Biovia)
13.8 Evotec AG
13.9 GVK Biosciences Private Limited
13.10 ICAGEN Inc.
13.11 Novo Informatics Pvt. Ltd.
13.12 Numerate Inc.
13.13 PerkinElmer Inc.
13.14 Schrdinger LLC
13.15 Selvita
13.16 Simulation Plus
13.17 WuXi AppTec
13.18 e-therapeutics plc (Snapshot)

For more information about this report visit https://www.researchandmarkets.com/r/2rpum3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets